ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK.

Mafalda Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.